It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Background
Research on the use of silver nanoparticles in the context of diabetes mellitus has gained attention due to the unique properties of these nanoparticles, such as their antimicrobial, anti-inflammatory, and antioxidant characteristics. While the field is still in its early stages, several studies have explored the potential applications and effects of silver nanoparticles in managing diabetes.
Main body of the abstract
Diabetes mellitus, a global health concern marked by impaired insulin function and high blood glucose levels, has spurred innovative therapeutic investigations, including nanotechnology. Silver nanoparticles have emerged as promising candidates in this pursuit. This abstract provides an overview of current research on silver nanoparticles’ application in managing diabetes mellitus, highlighting their therapeutic potential and mechanisms of action. With unique physicochemical properties like high surface area and bio-compatibility, silver nanoparticles are ideal for diverse biomedical applications. Recent studies show their ability to modulate key pathways in diabetes pathogenesis, enhancing insulin sensitivity, reducing oxidative stress, and supporting pancreatic beta-cell function. Their antimicrobial properties are particularly beneficial for diabetes patients prone to infections. Moreover, using silver nanoparticle-based carriers for anti-diabetic drugs improves drug bio-availability and reduces side effects, potentially enhancing conventional medication efficacy. However, addressing safety and toxicity concerns is crucial. Ongoing research focuses on optimizing nanoparticle size, shape, and surface modifications to enhance bio-compatibility and minimize adverse effects.
Short conclusion
In conclusion, silver nanoparticles represent a novel and multifaceted approach in the management of diabetes mellitus. Their ability to target multiple facets of diabetes pathogenesis, including insulin resistance, oxidative stress, and inflammation, positions them as potential candidates for future therapeutic interventions. However, further research is warranted to elucidate their long-term safety profile and optimize their application in clinical settings.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 NSHM Knowledge Campus, Department of Pharmaceutical Technology, Kolkata, India (GRID:grid.440742.1) (ISNI:0000 0004 1799 6713)
2 JIS University, Department of Pharmaceutical Technology, Kolkata, India (GRID:grid.513955.e) (ISNI:0000 0004 6006 1278)
3 NSHM Knowledge Campus, Department of Pharmaceutical Technology, Kolkata, India (GRID:grid.440742.1) (ISNI:0000 0004 1799 6713); Calcutta Institute of Pharmaceutical Technology and Allied Health Sciences, Uluberia, Howrah, India (GRID:grid.440742.1)